A deal brokered with the health department guarantees free access but for how long?
South Africa needs to increase its investment in science — if not, the country can’t beat HIV
Activists fear regulatory delays will come too late for many people who need delamanid and will also stall its release in neighbouring countries.
Tastier kid-friendly tablets will help take the guess work out of treating Kenya's tiniest TB patients.
From taxi driver to TB-care champion, Zamani Dlamini brings hope to the sick in rural KwaZulu-Natal.